Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boehringer ingelheim
3
×
eli lilly
europe blog main
europe top stories
3
×
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
abbvie
alzheimer's disease
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
fda
merck
moderna
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
type 2 diabetes
wisconsin blog main
wisconsin top stories
What
bio
debut
drug
moves
roundup
week
acquisitions
approval
bid
biggest
black
boehringer
build
buy
ceo
companies
company’s
continue
daniel
diabetes
diamond
diamond’s
dyne’s
eli
expand
fallen
fda
gilead
indication
ingelheim
leading
life
lilly
mammoth
march
marketed
medicine’s
microbiome
ohana’s
openly
Language
unset
Current search:
" boehringer ingelheim "
×
" europe top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More